OptiBiotix Health PLC (LON:OPTI) has signed a distribution agreement with BioEnergiser that will see its SlimBiome Medical weight loss supplements sold online in the UK.
SlimBiome Medical has been shown to reduce hunger, cravings for sweet and savoury foods, and fat intake.
READ: Opti continuing to put in place commercial building blocks
Today’s deal gives BioEnergiser the rights to distribute the supplements online within the UK, whilst still allowing Opti to continue to sell its product on its own online store.
The agreement provides market exclusivity linked to minimum sales orders to be agreed after a review of sales, pricing, and future forecasts, six months after signing this agreement.
“This is a significant and exciting step in accelerating the growth of OptiBiotix consumer health division,” said Fred Narbel, managing director of OptiBiotix’s prebiotics division.
“BioEnergiser's expertise in direct to consumer online sales and marketing will help build brand and consumer awareness of SlimBiome Medical through TV and national newspaper advertising, complementing any potential future retail launch.
The deal brings further value by providing us with economies of scale and will support revenue growth and profitability of OptiBiotix's prebiotics division going forward.”